Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camille Adajar

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
BMC Cancer|November 8, 2021
Cautious addition of targeted therapy to PD-1 inhibitors after initial progression of BRAF mutant metastatic melanoma on checkpoint inhibitor therapyWolfram Samlowski, Camille Adajar
Anesthesia and Analgesia|May 21, 2024
Letter to the EditorCamille Adajar, Akshay Thontakudi
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
BMC Cancer|November 8, 2021
Cautious addition of targeted therapy to PD-1 inhibitors after initial progression of BRAF mutant metastatic melanoma on checkpoint inhibitor therapyWolfram Samlowski, Camille Adajar
Anesthesia and Analgesia|May 21, 2024
Letter to the EditorCamille Adajar, Akshay Thontakudi
Pageof 1